Home / Recalls / Medical Devices
Migo Trading LLC recalls FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test
Recalled January 5, 2022 · FDA recall Z-0421-2022 · Migo Trading
Hazard
Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA). This product has not been authorized for emergency use and the test cannot be determined to be adequately validated for the stated intended use. · FDA Class II
Units
200,100 units
Sold at
NY
Description
Devices are determined to be inconsistent with the firm's Emergency Use Authorization (EUA). This product has not been authorized for emergency use and the test cannot be determined to be adequately validated for the stated intended use.
Product
FLOWFLEX SARS-COV-2 Antigen Rapid Test (Self-Testing), 1 Test
Manufacturer(s)
Migo Trading LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →